Amaxa Pharma Ltd

POWER SEARCH PRICING

SOLUTIONS

amaxa pharma ltd Company Information

Live

EstablishedSmallDeclining

Company Number

08102507

Next Accounts

Mar 2025

Industry

Other personal service activities n.e.c.

Directors

Vladimir Tkachenko

Shareholders

vladimir tkachenko

Group Structure

View All

Contact

Registered Address

73 great peter street, london, SW1P 2BN

Website

http://amaxa.uk

amaxa pharma ltd Estimated Valuation

£1.1m

Pomanda estimates the enterprise value of AMAXA PHARMA LTD at £1.1m based on a Turnover of £1.9m and 0.56x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

Amaxa Pharma Ltd is a live company located in london, SW1P 2BN with a Companies House number of 08102507. It operates in the other service activities n.e.c. sector, SIC Code 96090. Founded in June 2012, it's largest shareholder is vladimir tkachenko with a 100% stake. Amaxa Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £1.9m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Amaxa Pharma Ltd a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Rating2.5out of 5

3 Strong

1 Regular

6 Weak

Size

annual sales of £1.9m, make it larger than the average company (£905k)

Growth

3 year (CAGR) sales growth of -40%, show it is growing at a slower rate (5.7%)

EXPORT

Amaxa Pharma Ltd's latest turnover from June 2023 is estimated at £1.9 million and the company has net assets of £190.4 thousand. According to their latest financial statements, Amaxa Pharma Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013
Turnover	1,897,948	2,282,050	5,266,918	8,807,459	6,826,620	4,062,010	4,445,344	2,905,809	3,104,267	1,374,215	1,006,729
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,514,209	1,845,691	4,340,643	7,092,569	5,503,415	3,254,821	3,533,359	2,280,075	2,431,732	1,090,016	782,016
Gross Profit	383,739	436,358	926,275	1,714,891	1,323,204	807,189	911,985	625,734	672,536	284,199	224,713
Admin Expenses	327,493	974,432	802,763	1,604,870	1,180,966	709,793	842,116	586,244	530,582	242,147	181,511
Operating Profit	56,246	-538,074	123,512	110,021	142,238	97,396	69,869	39,490	141,954	42,052	43,202
Interest Payable	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	1,904	2,522	432	1,268	11,501	4,586	2,030	5,522	6,053	4,888	2,213
Pre-Tax Profit	58,150	-535,552	123,944	111,289	153,739	101,982	71,899	45,012	148,007	46,940	45,416
Tax	-14,537	0	-23,549	-21,145	-29,210	-19,377	-13,661	-9,002	-29,601	-9,857	-10,446
Profit After Tax	43,612	-535,552	100,395	90,144	124,529	82,606	58,238	36,010	118,405	37,083	34,970
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	43,612	-535,552	100,395	90,144	124,529	82,606	58,238	36,010	118,405	37,083	34,970
Employee Costs	30,750	29,074	27,940	26,781	54,441	26,033	25,083	53,231	501,010	210,667	183,220
Number Of Employees	1	1	1	1	2	1	1	2	19	8	7
EBITDA*	56,246	-517,146	145,259	132,567	171,337	126,445	94,183	80,549	141,954	42,052	43,202

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013
Tangible Assets	83,718	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	104,648	130,493	210,812	233,359	267,369	267,387	73,970	0	0	0
Investments & Other	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	83,719	104,648	130,493	210,812	233,359	267,369	267,387	73,970	0	0	0
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	714,168	907,449	2,173,474	3,206,646	2,165,105	1,302,617	1,488,986	814,416	394,576	53,077	7,059
Group Debtors	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	13,523	10,958	34,040	11,902	134,555	11,807	58,298	0	0	0
Cash	0	76,165	327,397	537,239	1,999,232	1,067,816	766,701	857,334	1,351,519	1,069,739	885,397
misc current assets	0	0	0	0	0	0	0	0	0	0	0
total current assets	714,168	997,137	2,511,830	3,777,926	4,176,239	2,507,741	2,267,494	1,730,049	1,746,096	1,122,817	892,456
total assets	797,886	1,101,786	2,642,323	3,988,738	4,409,598	2,775,110	2,534,881	1,804,019	1,746,096	1,122,817	892,456
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	607,446	835,426	1,813,489	2,919,670	3,424,089	1,921,896	2,051,818	1,552,440	1,554,565	1,049,783	856,238
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	118,463	145,344	486,007	492,591	475,082	197,282	24,017	0	0	0
total current liabilities	607,446	953,890	1,958,833	3,405,677	3,916,681	2,406,702	2,249,101	1,576,457	1,554,565	1,049,783	856,238
loans	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	0	0	0	0	0	0	0	0
total liabilities	607,446	953,890	1,958,833	3,405,677	3,916,681	2,406,702	2,249,101	1,576,457	1,554,565	1,049,783	856,238
net assets	190,440	147,896	683,490	583,061	492,917	368,408	285,781	227,562	191,531	73,033	36,218
total shareholders funds	190,440	147,896	683,490	583,061	492,917	368,408	285,781	227,562	191,531	73,033	36,218

	Jun 2023	Jun 2022	Jun 2021	Jun 2020	Jun 2019	Jun 2018	Jun 2017	Jun 2016	Jun 2015	Jun 2014	Jun 2013
Operating Activities
Operating Profit	56,246	-538,074	123,512	110,021	142,238	97,396	69,869	39,490	141,954	42,052	43,202
Depreciation	0	0	0	0	0	0	0	0	0	0	0
Amortisation	0	20,928	21,747	22,546	29,099	29,049	24,314	41,059	0	0	0
Tax	-14,537	0	-23,549	-21,145	-29,210	-19,377	-13,661	-9,002	-29,601	-9,857	-10,446
Stock	0	0	0	0	0	0	0	0	0	0	0
Debtors	-206,805	-1,263,460	-1,056,254	1,063,679	765,959	-89,745	628,078	478,139	341,499	46,018	7,059
Creditors	-227,980	-978,062	-1,106,181	-504,420	1,502,193	-129,922	499,378	-2,125	504,782	193,545	856,238
Accruals and Deferred Income	-118,463	-26,881	-340,663	-6,584	17,509	277,800	173,265	24,017	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	-97,929	-258,629	-268,880	-1,463,261	895,870	344,691	125,087	-384,700	275,636	179,722	881,935
Investing Activities
capital expenditure	20,930	4,917	58,572	1	4,911	-29,032	-217,731	-115,029	0	0	0
Change in Investments	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	20,930	4,917	58,572	1	4,911	-29,032	-217,731	-115,029	0	0	0
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0
share issue	-1,068	-42	34	0	-21	22	-19	21	92	-268	1,248
interest	1,904	2,522	432	1,268	11,501	4,586	2,030	5,522	6,053	4,888	2,213
cash flow from financing	836	2,480	466	1,268	11,480	4,608	2,011	5,543	6,145	4,620	3,461
cash and cash equivalents
cash	-76,165	-251,232	-209,842	-1,461,993	931,416	301,115	-90,633	-494,186	281,780	184,342	885,397
overdraft	0	0	0	0	0	0	0	0	0	0	0
change in cash	-76,165	-251,232	-209,842	-1,461,993	931,416	301,115	-90,633	-494,186	281,780	184,342	885,397

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for amaxa pharma ltd. Get real-time insights into amaxa pharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for amaxa pharma ltd by selecting its closest rivals, whether from the OTHER SERVICE ACTIVITIES sector, other small companies, companies in SW1P area or any other competitors across 12 key performance metrics.

AMAXA PHARMA LTD group structure

Amaxa Pharma Ltd has no subsidiary companies.

Ultimate parent company

AMAXA PHARMA LTD

08102507

AMAXA PHARMA LTD Shareholders

vladimir tkachenko

100%

Amaxa Pharma Ltd currently has 1 director, Mr Vladimir Tkachenko serving since Mar 2017.

officer	country	age	start	end	role
Mr Vladimir Tkachenko	England	53 years	Mar 2017	-	Director

P&L

June 2023

turnover

1.9m

-17%

operating profit

56.2k

gross margin

20.3%

+5.74%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

June 2023

net assets

190.4k

+0.29%

total assets

797.9k

-0.28%

cash

-1%

net assets

Total assets minus all liabilities

Similar Companies

2.5

3.5

4.5

search fine art limited

company number

08102507

Type

Private limited with Share Capital

industry

96090 - Other personal service activities n.e.c.

incorporation date

June 2012

ultimate parent company

None

previous names

N/A

address

73 great peter street, london, SW1P 2BN

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to amaxa pharma ltd.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for AMAXA PHARMA LTD. This can take several minutes, an email will notify you when this has completed.

amaxa pharma ltd Company Information

amaxa pharma ltd Estimated Valuation

amaxa pharma ltd Estimated Valuation

amaxa pharma ltd Estimated Valuation

Amaxa Pharma Ltd Overview

Amaxa Pharma Ltd Health Check

AMAXA PHARMA LTD financials

amaxa pharma ltd Credit Report and Business Information

Amaxa Pharma Ltd Competitor Analysis

amaxa pharma ltd Ownership

amaxa pharma ltd directors

amaxa pharma ltd company details

amaxa pharma ltd Charges & Mortgages

amaxa pharma ltd Capital Raised & Share Issues BETA

amaxa pharma ltd Companies House Filings - See Documents